(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...
The TO_AITION project, completed this month (December 2025), has been investigating the biological causes of inflammation linking cardiovascular diseases (CVD) and depression, and has used a wide ...
TUESDAY, Aug. 12, 2025 (HealthDay News) -- Inflammatory pathways that contribute to asthma exacerbations have been identified in children with eosinophilic asthma receiving mepolizumab, according to a ...
The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...
Scientists have spotted a new variety of riled-up microglia that drives swelling in the human brain. In the November 18 Neuron, researchers from China led by Haixiao Liu, Shunnan Ge, and Yan Qu at ...
This image illustrates the immunomodulation of chronic wounds through various therapeutic approaches aimed at regulating the immune response to promote healing. Chronic wounds exhibit persistent ...
Echo is spotlighting peer-reviewed research that explores how hydrogen-rich water may complement traditional psychological care. The study, published in Health Psychology Research, investigated the ...
CKD and HF often coexist, worsening outcomes due to shared risk factors and biological pathways like inflammation and neurohormonal activation. CKD is frequently underdiagnosed in HF patients, with ...
The findings suggest that dampening eosinophilic and T2 inflammatory responses result in increases in several alternative inflammatory pathways that contribute to residual exacerbations in children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback